Astellas Pharma Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Astellas Pharma Inc. (Astellas or ‘the company’) manufactures, markets, develops, import and export of pharmaceuticals and related products. It manufactures prescription drugs in therapeutic areas of urology, oncology, immunology, nephrology, muscle diseases and neuroscience. It provides drugs for different types of cancer including, prostate cancer, urothelial cancer and anemia associated with chronic kidney disease. The company sells its products under Gaster, Geninax Gonax, Harnal/Omnic, Funguard, Prograf, Vesicare, Geninax and Eligard among others brand names. Astellas operates research centers in Japan. The company has business operations across Japan, the Americas, Europe, Middle East, and Africa (EMEA), Asia and Oceania. The company is headquartered in Chuo-Ku, Tokyo, Japan.Scope
- Detailed information on Astellas Pharma Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Astellas Pharma Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Astellas Pharma Inc. including a breakdown and examination of key business segments
- Intelligence on Astellas Pharma Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Astellas Pharma Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of Astellas Pharma Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Astellas Pharma Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Astellas Pharma Inc.'s business structure, strategy and prospects.
Table of Contents
- Company Snapshot
- Astellas Pharma Inc.: Company Overview
- Astellas Pharma Inc.: Overview and Key Facts
- Astellas Pharma Inc.: Overview
- Astellas Pharma Inc.: Key Facts
- Astellas Pharma Inc.: Key Employees
- Astellas Pharma Inc.: Key Employee Biographies
- Astellas Pharma Inc.: Major Products and Services
- Astellas Pharma Inc.: Management Statement
- Astellas Pharma Inc.: Locations and Subsidiaries
- Astellas Pharma Inc.: Key Competitors
- Astellas Pharma Inc.: Company Analysis
- Astellas Pharma Inc.: Business Description
- Astellas Pharma Inc.: SWOT Analysis
- Astellas Pharma Inc.: SWOT Overview
- Astellas Pharma Inc.: Strengths
- Astellas Pharma Inc.: Weaknesses
- Astellas Pharma Inc.: Opportunities
- Astellas Pharma Inc.: Threats
- Astellas Pharma Inc.: Corporate Financial Deals Activity
- Astellas Pharma Inc.: Financial Deals Overview
- Astellas Pharma Inc.: Targets and Partners
- Astellas Pharma Inc.: Top Deals 2020 - 2024YTD*
- Astellas Pharma Inc.: Advisors
- Astellas Pharma Inc.: Top Legal Advisors
- Astellas Pharma Inc.: Top Financial Advisors
- Astellas Pharma Inc.: Mergers and Acquisitions
- Astellas Pharma Inc.: Corporate Venturing
- Astellas Pharma Inc.: Capital Raising
- Astellas Pharma Inc.: Partnership
- Astellas Pharma Inc.: Divestments
- Astellas Pharma Inc.: Recent Developments
- Astellas Pharma Inc.: News and Events Summary
- Astellas Pharma Inc.: Business Expansion
- Astellas Pharma Inc.: Business Reorganization
- Astellas Pharma Inc.: Contracts
- Astellas Pharma Inc.: Financial Performance
- Astellas Pharma Inc.: Market Developments
- Astellas Pharma Inc.: Research & Development
- Astellas Pharma Inc.: Strategy and Operations
- Appendix
- Contact the Publisher
- Methodology
- About the Publisher
- Table 1: Astellas Pharma Inc.: Key Facts
- Table 2: Astellas Pharma Inc.: Key Employees
- Table 3: Astellas Pharma Inc.: Locations and Subsidiaries
- Table 4: Astellas Pharma Inc.: Key Competitors
- Table 5: Astellas Pharma Inc.: Deal Activity by Deal Type - Volume (TTM*)
- Table 6: Astellas Pharma Inc.: M&A Activity by Geography (TTM*)
- Table 7: Astellas Pharma Inc.: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
- Table 8: Astellas Pharma Inc.: M&A Average Deal Size - Value (US$m)
- Table 9: Astellas Pharma Inc.: Targets and Partners
- Table 10: Astellas Pharma Inc.: Top Deals 2020 - 2024YTD*
- Table 11: Astellas Pharma Inc.: Legal Advisor Ranking by Value (US$m)
- Table 12: Astellas Pharma Inc.: Financial Advisor Ranking by Value (US$m)
- Table 13: Astellas Pharma Inc.: M&A Volume and Value Trend (2020 - YTD*2024)
- Table 14: Astellas Pharma Inc.: M&A Activity by Geography (2020 - YTD*2024)
- Table 15: Astellas Pharma Inc.: Corporate Venturing Volume and Value Trend (2020 - YTD*2024)
- Table 16: Astellas Pharma Inc.: Corporate Venturing by Geography (2020 - YTD*2024)
- Table 17: Astellas Pharma Inc.: Capital Raising Volume and Value Trend (2020 - YTD*2024)
- Table 18: Astellas Pharma Inc.: Capital Raising by Deal Type (2020 - YTD*2024)
- Table 19: Astellas Pharma Inc.: Partnership Volume and Value Trend (2020 - YTD*2024)
- Table 20: Astellas Pharma Inc.: Partnership Trend by Deal Type (2020 - YTD*2024)
- Table 21: Astellas Pharma Inc.: Divestments Volume and Value Trend (2020 - YTD*2024)
- Table 22: Astellas Pharma Inc.: Divestments by Geography (2020 - YTD*2024)
- Table 23: Astellas Pharma Inc.: News and Events Summary
- Table 24: Astellas Pharma Inc.: Business Expansion
- Table 25: Astellas Pharma Inc.: Business Reorganization
- Table 26: Astellas Pharma Inc.: Contracts
- Table 27: Astellas Pharma Inc.: Financial Performance
- Table 28: Astellas Pharma Inc.: Market Developments
- Table 29: Astellas Pharma Inc.: Research & Development
- Table 30: Astellas Pharma Inc.: Strategy and Operations
- Figure 1: Astellas Pharma Inc.: Deal Activity by Deal Type - Volume (TTM*)
- Figure 2: Astellas Pharma Inc.: M&A Activity by Geography (TTM*)
- Figure 3: Astellas Pharma Inc.: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
- Figure 4: Astellas Pharma Inc.: M&A Average Deal Size - Value (US$m)
- Figure 5: Astellas Pharma Inc.: M&A Volume and Value Trend (2020 - YTD*2024)
- Figure 6: Astellas Pharma Inc.: M&A Activity by Geography (2020 - YTD*2024)
- Figure 7: Astellas Pharma Inc.: Corporate Venturing Volume and Value Trend (2020 - YTD*2024)
- Figure 8: Astellas Pharma Inc.: Corporate Venturing by Geography (2020 - YTD*2024)
- Figure 9: Astellas Pharma Inc.: Capital Raising Volume and Value Trend (2020 - YTD*2024)
- Figure 10: Astellas Pharma Inc.: Capital Raising by Deal Type (2020 - YTD*2024)
- Figure 11: Astellas Pharma Inc.: Partnership Volume and Value Trend (2020 - YTD*2024)
- Figure 12: Astellas Pharma Inc.: Partnership Trend by Deal Type (2020 - YTD*2024)
- Figure 13: Astellas Pharma Inc.: Divestments Volume and Value Trend (2020 - YTD*2024)
- Figure 14: Astellas Pharma Inc.: Divestments by Geography (2020 - YTD*2024)
